Meharry Medical College Logo
 
  EVENTS CALENDAR
  CONTACT US
  EMPLOYMENT
bANNER sELF SERVICE
eMPLOYEE dIRECTORY
  DIGITAL LIBRARY


   
 
 
Education
Research
Patient Care
 
Meharry Medical College School Of Medicine Worship of God Through Service To Mankind
Biomedical Sciences Department Family Medicine Medical Education Neurology
OB/GYN Home Pathology Pediatrics Psychiatry and Behavioral Sciences
Radiology Surgery Clerkship Department of Surgery Department of Internal Medicine
Divisions Department History Fellowship Programs Research Centers
Research Programs Faculty Residency Training Education & Training
Medical Grand Rounds News & Events Reach Us School of Medicine Home
 
New_Medicine

News & Events
Newsletter of Summer 2006
Newsletter of Spring 2006
Newsletter of Fall 2005

Newsletter of Spring 2005  
Newsletter of Winter 2004 


 Dr. Steven Wolff’s interview with the Tennessean regarding Sickle Cell Disease
Dr. Steven Wolff, director of Meharry Sickle Cell Center in Nashville, said the disease can impair vision and hamper the immune system, making children much more vulnerable to infections of the blood and lungs. The disease causes anemia and liver damage, which often leads to jaundice or yellowing of the skin and eyes. Many sickle cell patients need joint replacement surgery when they get older. The disease can cause fatal complications such as strokes and kidney failure.

The Department hosted 2005 Pfizer Visiting Professor
Dr. Talmadge E. King, Jr., Chief of Medical Services at San Francisco General Hospital and the Constance B. Wofsy Distinguished Professor and Vice Chair of Medicine at UCSF, visited Meharry Nov. 8-10.
He is the world renowned scholar, pulmonologist and researcher. He was the Department’s Visiting Professor The Department of Internal Medicine at Meharry sought the competitive grant because of the prevalence of pulmonary diseases in the region served by the College. Dr. King’s special expertise in the area of pathophysiology and immunology of inflammatory lung disease will be the cornerstone of his didactic lectures and practical instruction. 

New Director of Meharry HIV Center
Noted HIV/AIDS researcher, Dr. James Hildreth, was appointed as the director of Meharry Center for Health Disparities research in HIV. He began July 1, 2005.
BiDil was approved by FDA
BiDil treats heart failure in blacks won FDA approval on June 25, 2005, becoming the first medicine that targets people of just one race. Dr.Theodore Addai was quoted and pictured in a story.

Medical Grand Rounds Featured Speaker
Dr. Lee B. Reichman ( Professor of Medicine, Preventive Medicine and Community Health Executive Director, New Jersey Medical School National Tuberculosis Center ) , had a talk "The Most Misunderstood Diagnostic Test of All"on March 23, 2005 at Meharry Medical College Internal Medicine Grand Rounds.
HIV/AIDS Education and Training
The National Minority AIDS Education and Training Center hosted two events. 1)Group consultation Meeting-- "Nutrition and HIV: Essential Guide for Providers"was on January 26, 2005. This seminar will occur every fouth Wednesday of the month except November and December; 2) One Day HIV/AIDS Training Preceptorship Programwas on January 28, 2005.  The topics included update HAART guidelines, manifestations of HIV, biopsychosocial needs of HIV/aids patients, cultural competency, HIV and substance use, and STD'S & HIV. Clinical Training may be scheduled upon request.    
BiDil is the First Medicine for Blacks to Prevent Heart Failure
Dr. Addai , an Associate Professor of  t he Division of Cardiology, led the BiDil clinical trial at Meharry Clinical Research Center, one of 170 clinical sites participating in a wider trial involving 1,050 African-American heart failure patients either on BiDil or a placebo. The BiDil trial showed mortality rates fell 43 percent, first hospital visits fell 33 percent and that quality of life improved for patients. BiDil would likely be approved by the FDA on February, 2005. The results of the wider study were printed in the Nov. 11 issue of The New England Journal of Medicine .
The 2004 Workshop on Disparities and the HIV Epidemic
This national meeting was held in Nashville from Nov. 18-19, 2004 to inform clinicians about racial/ethnic and gender disparities that affect practice and allow clinical and basic researchers from diverse disciplines to exchange state-of-the-art ideas regarding 1)Racial/ethnic and gender disparities in the epidemiology, pathogenesis, and treatment/vaccine responses of HIV and other pathogens (such as HCV and M. tuberculosis ). 2) Current research on biological and genetic mechanisms that may underlie these disparities (such as pharmacogenomics and host factors involved in HIV replication). 3)Invited expert speakers will present definitive updates. There had the Oral and poster sessions.